These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23769224)

  • 1. Tamoxifen therapy for patients with breast cancer.
    Huiart L; Ferdynus C; Giorgi R
    Lancet; 2013 Jun; 381(9883):2077. PubMed ID: 23769224
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen therapy for patients with breast cancer.
    Neven P; Joensuu H; Osborne K; Cardoso F; Loibl S; Linn S; Goldhirsch A; Ortmann O; Senn HJ; Hayes DF
    Lancet; 2013 Jun; 381(9883):2078. PubMed ID: 23769226
    [No Abstract]   [Full Text] [Related]  

  • 3. The Atlas trial: Tamoxifen for a longer duration for early breast cancer.
    Raina V
    Natl Med J India; 2013; 26(1):4-5. PubMed ID: 24066985
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen therapy for patients with breast cancer.
    Litton J; Buzdar A; Mac Gregor MC; Gonzalez-Angulo A; Hortobagyi G
    Lancet; 2013 Jun; 381(9883):2077-8. PubMed ID: 23769223
    [No Abstract]   [Full Text] [Related]  

  • 5. Stopping tamoxifen after 5 years of therapy for early breast cancer: does it alter quality of life?
    Hall PS; Walkington JP; Cameron DA
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):652. PubMed ID: 21703830
    [No Abstract]   [Full Text] [Related]  

  • 6. [For how long should breast cancer patients take Tamoxifen? The International Program ATLAS will answer this question].
    Semiglazov VF
    Vopr Onkol; 1998; 44(4):373-7. PubMed ID: 9807196
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.
    Fink AK; Gurwitz J; Rakowski W; Guadagnoli E; Silliman RA
    J Clin Oncol; 2004 Aug; 22(16):3309-15. PubMed ID: 15310774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?
    Huiart L; Bouhnik AD; Rey D; Tarpin C; Cluze C; Bendiane MK; Viens P; Giorgi R
    Eur J Cancer; 2012 Sep; 48(13):1939-46. PubMed ID: 22464016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to endocrine therapy for breast cancer.
    Partridge AH
    Ann Oncol; 2006 Feb; 17(2):183-4. PubMed ID: 16428243
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of adjuvant endocrine therapy for postoperative breast cancer patients].
    Doihara H; Ogasawara Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():563-7. PubMed ID: 17682212
    [No Abstract]   [Full Text] [Related]  

  • 12. Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer.
    Myrick ME; Schmid SM; Kilic N; Güth U
    Acta Oncol; 2012 Feb; 51(2):247-53. PubMed ID: 21985132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence beliefs among breast cancer patients taking tamoxifen.
    Grunfeld EA; Hunter MS; Sikka P; Mittal S
    Patient Educ Couns; 2005 Oct; 59(1):97-102. PubMed ID: 16198223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen for breast cancer.
    Karn A; Jha AK; Shrestha S; Acharya B; Poudel S; Bhandari RB
    JNMA J Nepal Med Assoc; 2010; 49(177):62-7. PubMed ID: 21180225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
    Ward JH
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):51-5. PubMed ID: 19952743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualization of tamoxifen treatment for breast carcinoma.
    Binkhorst L; van Gelder T; Mathijssen RH
    Clin Pharmacol Ther; 2012 Oct; 92(4):431-3. PubMed ID: 22910442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended adjuvant tamoxifen for breast cancer--a new era?
    Powles TJ
    Lancet; 2013 Mar; 381(9869):782-3. PubMed ID: 23219287
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen in early breast cancer.
    Bryce CJ
    Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!
    Bentzen SM; Yarnold JR
    J Clin Oncol; 2005 Sep; 23(25):6266-7; author reply 6267. PubMed ID: 16135499
    [No Abstract]   [Full Text] [Related]  

  • 20. Combo drug therapy doubles breast cancer survival rates. Early treatment with Tamoxifen-chemotherapy combination often extends life.
    Health News; 2005 Aug; 11(8):3-4. PubMed ID: 16184637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.